DDC Enterprise (NASDAQ: DDC) director lists shares, warrants, options and RSUs in Form 3

Rhea-AI Filing Summary

DDC Enterprise Ltd director Matthew Gene Mouw filed an initial ownership report listing his equity interests in the company. The filing shows he directly holds Class A ordinary shares, warrants, stock options, and restricted stock units, providing a detailed view of his current position.

His derivative holdings include warrants exercisable at $0.1600 per share with expiration dates in 2035, and stock options exercisable at $5.5000 per share with expirations also in 2035. He also reports multiple tranches of restricted stock units with a $0.0000 exercise price and expirations in 2035, alongside 20,000 Class A ordinary shares held directly.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mouw Matthew Gene

(Last) (First) (Middle)

368 9TH AVE

(Street)

NEW YORK NEW YORK 10001

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
DDC Enterprise Ltd [ DDC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Ordinary Shares	20,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrants	12/30/2025	09/29/2035	Warrants	33,333	$0.16	D
Warrants	03/16/2026	12/30/2035	Warrants	33,333	$0.16	D
Stock Options	02/22/2025	02/21/2035	Stock Options	20,000	$5.5	D
Stock Options	05/22/2025	02/22/2035	Stock Options	2.841	$5.5	D
Stock Options	08/22/2025	02/22/2035	Stock Options	2.841	$5.5	D
Stock Options	11/22/2025	02/22/2035	Stock Options	2.841	$5.5	D
Stock Options	02/22/2026	02/22/2035	Stock Options	2.841	$5.5	D
Stock Options	05/22/2026	02/22/2035	Stock Options	2.841	$5.5	D
Stock Options	08/22/2026	02/22/2035	Stock Options	2.841	$5.5	D
Stock Options	11/22/2026	02/22/2035	Stock Options	2.841	$5.5	D
Stock Options	02/22/2027	02/22/2035	Stock Options	2.841	$5.5	D
Stock Options	05/22/2027	02/22/2035	Stock Options	2.841	$5.5	D
Stock Options	08/22/2027	02/22/2035	Stock Options	2.841	$5.5	D
Stock Options	11/22/2027	02/22/2035	Stock Options	2.841	$5.5	D
Stock Options	02/22/2028	02/22/2035	Stock Options	2.841	$5.5	D
Stock Options	05/22/2028	02/22/2035	Stock Options	2.841	$5.5	D
Stock Options	08/22/2028	02/22/2035	Stock Options	2.841	$5.5	D
Stock Options	11/22/2028	02/22/2035	Stock Options	2.841	$5.5	D
Stock Options	02/22/2029	02/22/2035	Stock Options	2.839	$5.5	D
Restricted Stock Unit	12/13/2026	12/13/2035	Restricted Stock Unit	30,487	$0.00	D
Restricted Stock Unit	12/13/2027	12/13/2035	Restricted Stock Unit	30,487	$0.00	D
Restricted Stock Unit	12/13/2028	12/13/2035	Restricted Stock Unit	30,488	$0.00	D
Restricted Stock Unit	12/13/2029	12/13/2035	Restricted Stock Unit	30,489	$0.00	D

Explanation of Responses:

	/s/ Matthew Gene Mouw_	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the DDC Form 3 for Matthew Gene Mouw report?

The Form 3 for DDC director Matthew Gene Mouw reports his initial ownership in the company, including Class A ordinary shares, warrants, stock options, and restricted stock units, all held directly, along with their exercise prices and expiration dates as disclosed.

How many DDC Class A ordinary shares does Matthew Gene Mouw hold?

The filing shows Matthew Gene Mouw directly holds 20,000 Class A ordinary shares of DDC Enterprise Ltd. This position is in addition to his warrants, stock options, and restricted stock units reported in the same Form 3.

What warrant holdings for DDC does Matthew Gene Mouw report?

He reports warrants with underlying securities of 33,333 shares each, exercisable at $0.1600 per share, with expiration dates in September 2035 and December 2035. These warrant positions are held directly, according to the filing data.

What stock option grants are disclosed for Matthew Gene Mouw in DDC?

The Form 3 discloses stock options with an exercise price of $5.5000 per share, including a tranche over 20,000 underlying shares expiring in 2035, plus several smaller option tranches with the same exercise price and similar expiration timing.

What restricted stock units does Matthew Gene Mouw hold in DDC Enterprise Ltd?

He holds multiple restricted stock unit tranches with a $0.0000 exercise price and expiration dates in 2035, including positions over 30,487, 30,488, and 30,489 underlying shares, all reported as directly owned in the Form 3.

Does the DDC Form 3 show any insider buying or selling by Matthew Gene Mouw?

The transaction summary shows only holding entries and no buy or sell transactions, with buyCount and sellCount both at zero. This indicates the filing is focused on reporting existing ownership positions rather than new market trades.